Masaya Hattori

11PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Clinical midwiferyMolecular targetsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 01, 2025
Supraclavicular Irradiation Induces Lymphedema in Breast Cancer Patients Treated with Axillary Lymph Node Dissection and Taxane-Containing Chemotherapy.

Nanae Horisawa, Akiyo Yoshimura, Isao Oze

|Dec 10, 2024
Role of circulating tumor cells in breast cancer.

Masaya Hattori

|Sep 12, 2024
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01.

Aditya Bardia, Komal Jhaveri, Seock-Ah Im

|May 26, 2024
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study.

Ayaka Isogai, Kazuki Nozawa, Akira Nakakami

|Apr 18, 2024
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project.

Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito

|Aug 01, 2023
Fulvestrant with or without anti-HER2 therapy in patients in a postmenopausal hormonal state and with ER-positive HER2-positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG-C06).

Misato Masuyama, Norikazu Masuda, Hidetoshi Kawaguchi

Pageof 2

Frequent Collaborators

6 joint publications

Hiroji Iwata

5 joint publications

Kazuki Nozawa

4 joint publications

Yuka Endo

4 joint publications

Akiyo Yoshimura